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Fibromyalgia is a prevalent pain condition that is as ociated with cognitive impairments 
including in attention, memory, and executive processing. It has been proposed that fibromyalgia 
may be caused by altered central pain processing chara terised by a loss of endogenous pain 
modulation. We tested whether attentional analgesia, where cognitive engagement diminishes pain 
percept, was attenuated in fibromyalgia patients (n=20) compared to matched healthy controls 
(n=20). An individually calibrated, attentional analgesia paradigm with a 2x2 block design was used 
with brain and brainstem-focussed fMRI. Fibromyalgi patients had both lower heat pain thresholds 
and speeds in a visual attention task. When this was taken into account for both attentional task and 
thermal stimulation, then both groups exhibited an equivalent degree of attentional analgesia.  fMRI 
analysis showed similar patterns of activation in the main effects of pain and attention in the brain 
and brainstem (with the sole exceptions of increased ctivation in the control group in frontopolar 
cortex and the ipsilateral locus coeruleus). The att ntional analgesic effect correlated with activity 
in the periaqueductal grey and rostroventromedial medulla. These findings indicate that 
fibromyalgia patients can engage the descending pain modulatory system if the attentional task and 
noxious stimulus intensity is appropriately titrated. 
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INTRODUCTION 
Fibromyalgia is a common, chronic condition characterised by widespread pain with 
hyperalgesia in muscles and joints without any identifiable alternative causative pathology 
[6,70,84]. In addition to widespread pain, fibromyalgi  is syndromically-linked to fatigue, sleep 








“fibrofog” [43,81]. A single underlying pathophysiological cause for fibromyalgia is yet to be fully 
elucidated [69] and the current diagnostic criteria a e based on self-reported measures [75,82,83]. 
There are a plethora of studies reporting alterations n nociception and pain processing in 
patients with fibromyalgia.  One intriguing line of investigations has reported a small fibre deficit 
and altered function of nociceptive primary afferents [31,50,56,72,77] which may give rise to 
hyperalgesia. As a counterpoint theory, fibromyalgia has also been proposed to be a “centralised” 
pain condition [12] characterised by augmented brain responses to noxious stimuli that underlies 
hyperalgesia [15,30,66]. In support of a central aetiology of fibromyalgia, there have been reports 
of impairments in endogenous pain modulatory mechanisms, such as conditioned pain modulation 
[8,42,49] and exercise induced analgesia [80]. Thishas, in part, been the justification for the use of 
treatments to boost central pain modulatory circuits through the use of monoaminergic re-uptake 
inhibitors (increasing noradrenaline and serotonin) which are amongst the few medications with any 
evidence of efficacy in fibromyalgia [7,12]. 
Endogenous pain modulation [60] can also be engaged by cognitive manipulations, such as 
placebo analgesia [4,19] or a shift in attentional focus [3,78]. In healthy subjects, attentional 
analgesia has been shown to involve brainstem structures such as the rostral ventromedial medulla 
(RVM), locus coeruleus (LC) and periaqueductal grey (PAG) [9,59,76,78] that mediate a 
component of their pain modulatory effects via endogenous monoamines [53,60]. These brainstem 
regions are intrinsically challenging to image [11] and have been only sparsely investigated in 
fibromyalgia despite being implicated as part of the causative central pathology. 
The known link between fibromyalgia and impaired cognitive performance in domains such as 
attention, memory and executive processing [16,26,29, 8] provides a rationale to investigate a form 
of endogenous analgesia that is driven by cognitive focus i.e. attentional analgesia. We 








fibromyalgia, and further that whole-brain/brainstem optimised fMRI could determine where any 
deficit originated within the descending pain modulatory system or the attentional network.   
 
METHODS 
The study had ethical approval from the NHS South Central Oxford B Research Ethics 
Committee (reference 13/SC/0617). All subjects gave written informed consent for study 
participation.  The study was undertaken in the Clinical Research and Imaging Centre at the 
University of Bristol (CRiCBristol). 
Recruitment 
Fibromyalgia patients were recruited from local pain management clinics by clinician referral 
and poster advertisements. Sex-matched, healthy control subjects were recruited using poster and 
email advertisements at the University of Bristol.  A l subjects were screened for participation by 
telephone prior to attending for their single session. To meet inclusion criteria, they required a 
confirmed clinical diagnosis of fibromyalgia for at least six months prior to entry into the study.  
Subjects were excluded if they had other chronic panful conditions, were pregnant, or had a history 
of neurological or major psychiatric illness. Additionally, for control subjects, the presence of 
significant medical disorder precluded participation.  Standard safety inclusion/exclusion criteria for 
participation in MRI studies were also applied. Allsubjects completed the Widespread Pain and 
Symptom Severity index [82] to validate the fibromyalgia diagnosis for patients and to confirm the 
absence of fibromyalgia symptoms for control subjects. 
A total of 54 subjects (32 patients, 22 controls) were screened for the study, of which 14 failed 
the screening (3 were left-handed, 9 were unable to attend, 1 was unable to lie flat in the scanner, 1 
did not pass the MRI screening).  Twenty right-handed fibromyalgia patients (mean age 43, range 
25-60, 18 females) and twenty right-handed, healthy subjects (mean age, 35 years, range 20-59 








average than the fibromyalgia patients (paired t-test, p=0.03). Patients were not required to alter 
their regular medications which included: non-opioid analgesics (n=13), opioids (9) tricyclic 
antidepressants/ Serotonin and Noradrenaline re-uptake inhibitors (n=11) and gabapentinoids (n=7).  
Experiment 
Written informed consent was taken and MRI safety questionnaires were completed on the day 
of study.  The subjects were told that the experiment was to examine the interaction between pain 
and attention in the brain with no mention of the pnomenon of attentional analgesia to avoid 
generating an expectation with regard to the study purpose.  The American College of 
Rheumatology (ACR) Widespread Pain and Symptom Severity index [82] was completed with the 
assistance of clinician experimenters. Assessments were also made using: Edinburgh Handedness 
Inventory [58]; PainDETECT [24]; the "Pain now” and “Pain on average” scales from the Brief 
Pain Inventory [13]; Hospital Anxiety and Depression scale (HADS, [87]) and Pain Anxiety 
Symptom Scales (PASS, [52]). Any medications taken in the 72 hours prior to the session were 
recorded for all participants.  
Both groups had a  thermal Quantitative Sensory Testing (QST)  with a circular contact 
thermode (CHEPS Pathway, MEDOC, Israel) applied on the left volar forearm using a modified 
version of the standardised protocol and script [67] (that included warm detection threshold, heat 
pain threshold, cold detection threshold and cold pain threshold). Study participants also had 
pressure pain threshold assessment over the thenar eminence using an algometer (Somedic, 
Sweden). After a short comfort / snack break, participants moved on to the calibration for the fMRI 
experiment.  
The experimental protocol was identical in structure to the one described in our previous studies 
[9,59]. Briefly, participants received thermal stimuli to their left forearm for 30s at either 36°C (low 
temperature) or 42-45°C (high temperature), and a pseudo-random series of 1 second long “spikes” 








The high temperature stimulus was calibrated for each indivdual to identify the thermal stimulus 
that produced a 6 out of 10 pain score. 
Participants were also calibrated for a rapid serial visual presentation (RSVP) attentional task 
[64], where they were presented with rapidly changing letters and numbers on a display screen and 
they were instructed to press a button when spotting he number 5. The task had two possible levels 
of difficulty (easy or hard). The task was individually titrated such that its speed of presentation 
(i.e. inter-stimulus interval, ISI) was performance matched to ability.  Each participant’s task 
performance was assayed over a range of ISIs (from 32 to 256 ms) by calculating d-prime (d’). The 
d’ values were fitted with a sigmoidal function and used to estimate the presentation speed 
corresponding to a 70% task performance which was used for their hard task during the 
experiment.  
The ISI for the easy task was set to: 
• 192 ms if the subject’s hard task ISI was < 96 ms 
• 256 ms if the hard ISI was ≥ 96 & < 256 ms 
• 384 ms if the hard ISI was = 256 ms 
The fMRI experiment had a 2x2 factorial design with four combinations for task and temperature 
(easy|high, hard|high, easy|low and hard|low) and has been described in detail previously [9,59]. 
Each experimental block lasted 70 seconds (comprising a fixation period with only a cross on the 
screen (17s), brief instruction to spot the target amongst distractors (5s), RSVP task performance 
and concurrent thermal stimulus (30s), a further fixation period (10s) and finally a rating period to 
obtain pain score (8s)). The blocks were presented i  pseudo-random sequence within sessions and 
across participants. Each combination was repeated 4 imes giving a total of 16 blocks.  Task 
performance (hits, misses and false alarms) was also recorded during the experiment. 








Brain images were acquired with a 3T Siemens Skyra whole-body MR system using the same 
acquisition sequences as our previous studies [9,59]. Briefly, subjects’ heads were positioned within 
the 32-channel receive only head coil, and memory fam pads placed around the skull to help 
minimise movement. Following acquisition of localiser images, a sagittal T1-weighted MPRAGE 
volumetric scan was acquired with TE/TR = 2.28/2200ms, flip angle = 9° and resolution of 0.86 x 
0.86 x 0.86mm, phase encoding direction = A-P, GRAPP  acceleration factor = 2. Functional 
imaging data were acquired with an echo planar imagng (EPI) sequence and GRAPPA acceleration 
factor = 2, TE/TR = 30/3000ms, flip angle = 90° and a resolution of 1.77 x 1.77 x 3.5mm. Finally, 
to correct image distortion in EPI data, a gradient echo field map was acquired with TE1/TE2/TR = 
4.92 / 7.38 / 520 ms, flip angle 60°, resolution 3 x  x 3.5 mm. During the fMRI experiment, 
cardiac and respiratory waveforms were recorded using pulse oximeter and respiratory bellows for 
subsequent physiological noise modelling [11].  
fMRI analysis 
Functional images were pre-processed and analysed in FEAT (FSL version 6 [39]). The pre-
processing pipeline was consistent with our previous papers [9,59] and included motion correction 
with MCFLIRT [38], fieldmap unwarping with FUGUE [37], registration to standard MNI template 
with FNIRT [1] and FLIRT [40], 4mm spatial smoothing and high-pass temporal filtering using a 
90 s cut-off. The general linear model (GLM) in FEAT, part of FSL, was used to assess brain 
activation to the four experimental conditions (easy|high, hard|high, easy|low and hard|low) and 
nuisance regressors (task instruction, rating periods), which were convolved with a hemodynamic 
response function. The design also included temporal derivatives, local autocorrelation correction 
(FILM [85]) and a set of regressors modelling physiological noise [10,33].  
Simple main effects were estimated by first creating difference contrasts between conditions at 
the first (i.e. subject) level e.g. (easy|high + hard|high) – (easy|low + hard|low) for the main effect of 








task difficulty. Note that the reverse contrast was also calculated. This process was repeated for the 
simple main effects of task, along with the interaction contrasts. Next, these difference contrast 
images were passed up to the second (i.e. group) level where one-sample t-tests were used for 
statistical inference (for pooled data) and two-sample t-tests (for estimation of group differences). 
For consistency, the same approach was used for both whole brain analysis with FEAT, and for 
masked analysis using RANDOMISE. The analysis approach taken is recommended by the 
developers of the FSL software package, as the GLM is not designed to model repeated measures in 
2x2 factorial designs. Whole brain group differences were assessed with an one-sample t-test in 
FEAT using a mixed-effects model (FLAME) and cluster-based correction for multiple comparison 
(with cluster forming threshold Z > 3.1 and cluster co rected p < 0.05 to adjust for family-wise 
error, in accordance with the latest recommendations f r spatial analysis of fMRI data [21]). 
The brainstem focussed analysis was performed at the group level using a set of anatomical 
masks and statistical inference using permutation testing [55] in RANDOMISE (part of FSL). This 
analysis utilised pre-defined regions of interest based on previously defined probabilistic masks of 
the a priori specified brainstem nuclei (PAG, RVM, and left / right LC, defined previously [9]). A 
two-sample unpaired t-test design was built with GLM (in FSL) in accordance with FEAT 
guidance. The number of permutations were set to 10,000 in line with guidelines [21] and results 
reported using threshold free cluster enhancement (TFCE) corrected p < 0.05. 
Where simple main effects or interactions were found in the imaging data, the nature of these 
differences was explored using FEATQUERY. Parameter stimates were extracted from each 
experimental condition (i.e. easy|low vs rest, hard|low vs rest, easy|high vs rest, hard|high vs rest) 
and their relationship to the individual behavioural responses examined. 
The magnitude of attention-mediated analgesia was compared to BOLD signal change in the 
brainstem nuclei (PAG, RVM and LC) specified a priori (as per our earlier study [9]). Average pain 








subtracted (i.e. easy|high – hard|high) and demeaned to obtain a group-level covariate. Th  
difference in the BOLD signal recorded for hard|high minus easy|high was correlated with the 
difference in pain ratings in an inter-subject parametric regression model. RANDOMISE was used 
to assess correlations in PAG, RVM, left and right LC masks. The latter analysis was done on the 
whole cohort (fibromyalgia patients and healthy contr ls).   
All whole brain results (group means and group comparisons) are reported for Z > 3.1, cluster 
corrected P < 0.05. All brainstem results are reported for P < 0.05, TFCE corrected.  
 
Questionnaire, QST and behavioural data analysis  
All statistical analyses (questionnaires, QST, pain r tings, task performance) were carried out in 
SPSS (version 26). Unpaired t-tests were used on questionnaire results to detect differences 
between patient and control groups.  
Hit rate (the proportion of correct responses to targets) and false alarm rate (the proportion of 
responses to non-targets) were calculated and z transformed. Subsequently, d’ was calculated as the 
difference between z transformed hit rate and z transformed false alarm rate.  The interstimulus 
intervals were compared with a Mann-Whitney U-test. 
Pain ratings and task performance recorded during the fMRI experiment were analysed with a  
mixed ANOVA (with two within-subject factors: task and temperature, and one between-subjects 
factor: group). A pre-specified post hoc comparison of the difference in pain scores between the 
easy|high vs hard|high condition was undertaken to identify any attentional analgesic effect. 
Prior to statistical analysis, data were examined for the presence of outliers, normality of 
distribution and equality of variance. Results are reported as mean ± standard deviation or median 











All patients met the ACR 2010 Diagnostic Criteria for ibromyalgia [82], scoring 13.5±2.6 on 
the Widespread Pain Index (WPI) and 10.0±1.5 [7-12] on the Symptom Severity (SS) scale score 
(WPI ≥7 and SS ≥5, Table 1).  None of the healthy controls met the ACR 2010 Diagnostic Criteria, 
scoring 1.0±1.0 [0-3] on the WPI and 2.0±1.1 [1-4] on the SS (Table 1).   
As expected, the fibromyalgia patients had higher ratings than the control group for the ‘pain 
now’ (5.3±1.6 vs 0.1±0.2 respectively, P < 0.0001) and ‘pain average’ (6.4±1.7 vs 0.7±1.0 
respectively, P < 0.0001, Table 1) domains of the BPI.  They also scored higher on the 
PainDETECT questionnaire compared to controls (15.7±8.2 vs 2.4±3.3 respectively, P < 0.0001, 
Table 1).  Fibromyalgia patients had elevated anxiety and depression scores (12.2±3.6 and 
10.5±4.7, with 17 and 15 patients scoring >8, respectiv ly) in comparison to healthy controls 
(4.6±4.0 and 1.3±1.3, with 3 scoring >8 for anxiety) on the HADS (P < 0.0001 in both cases, Table 
1).  Fibromyalgia patients also had higher scores in the cognitive, avoidance, fear and anxiety 
sections of PASS (all P < 0.0001, Table 1).   
 
Quantitative sensory testing 
Patients with fibromyalgia exhibited hyperalgesia to thermal and deep pressure stimuli when 
compare to controls. The heat pain threshold was lower in fibromyalgia patients (41.6±4.6°C 
fibromyalgia vs 45.3±3.9°C controls, P=0.01, unpaired t-test, Figure 1A) and the cold pain 
threshold was at a higher temperature (fibromyalgia 25.7°C [1.7 – 32°C] vs healthy controls 4.5°C 
[0 – 30.6°C], P = 0.001, Mann-Whitney test, Figure 1B). Similarly, the pressure pain threshold was 
lower in the fibromyalgia patients (fibromyalgia 162±18 vs control 265±25 kPa, P=0.0019, 
unpaired t-test, Figure 1C).  The warm detection thres old was higher in fibromyalgia patients 








There were two outliers in the fibromyalgia group and their exclusion reduced the difference in 
medians to 0.5˚C but the result remained significant (P=0.046).  There was no difference in cold 
detection threshold (30.6°C [23.7 – 13.2°C] vs 30.6°C [26.8 – 31.4°C], P = 0.73, Mann-Whitney 
test). 
 
Titration of thermal stimulation and task difficulty 
The percept calibrated high (painful) thermal stimulus to be used during fMRI was set at a lower 
temperature for the fibromyalgia patients, which was in keeping with thermal hyperalgesia 
identified by baseline QST. The temperature eliciting a pain intensity rating of 6 out of 10 was 
42±2°C for fibromyalgia patients and 43.1±1.7 °C for healthy controls (P=0.047, Figure 1E). The 
difficulty of the Hard RSVP task to be used during the experiment, was individually calibrated for 
each participant. Fibromyalgia patients required a longer interstimulus interval in the RSVP task to 
perform at 70% of optimal (fibromyalgia: 96ms [48 – 256ms] vs control: 64ms [32 – 96ms], 
P=0.008, Mann-Whitney test, Figure 1F). 
 
Pain ratings during the fMRI experiment 
The objective of the experiment was to examine whether the pain evoked by the thermal stimuli 
(low or high temperature) was affected by the concurrent performance of the RSVP attention task 
(easy or hard task). The behavioural data (pain scores) were initially pooled for both groups 
(Figure 2A). There was an expected main effect of temperature (F(1,38) = 174.8, P < 0.001, mixed 
ANOVA) and a temp*task interaction (F(1,38) = 13.1, P = 0.001, mixed ANOVA). There was no 
main effect of task (F(1,38) = 2.6, P = 0.12). A planned post-hoc analysis showed reduced pain in 
the hard|high (43.8±2.8) versus the asy|high (47.9±2.4) condition consistent with an attentional 








In the pooled analysis there were no differences betwe n the control and fibromyalgia groups 
(temp*group (F(1,38) = 0.2, P = 0.65); task*group (F(1,38) = 4.7, P = 0.66) or temp*task*group 
(F(1,38) = 0.01, P=0.97)).  To illustrate the behavioural similarity between the control group and 
the fibromyalgia patients the results are plotted sparately (Figure 2B-C).  In healthy controls a 
main effect of temperature and a task*temp interaction was evident (F(1,19) = 104.2, P < 0.0001 
and F(1,19) = 11.9, P = 0.003 respectively). Likewise, in fibromyalgia patients there was a main 
effect of temperature and a task*temp interaction (F(1,19) = 73.9, P < 0.0001, F(1,19) = 4.6, P = 
0.046, respectively). For both groups, post-hoc paired t-tests revealed that the interaction was due to 
an attentional analgesic effect with a decrease in pai scores in the hard|high versus the easy|high 
condition. 
 
Task performance in the fMRI experiment 
To assess performance on the RSVP task during the fMRI experiment, the subject’s button 
responses were recorded and used to calculate d’. We noted that controls performed the task better 
overall in the scanner as reflected in the between subject (i.e. group) effect (F(1,38) = 10.2, 
P=0.003) indicating that our initial calibration (outside the scanner) did not fully compensate for the 
differences in performance levels between the groups when they were challenged within the scanner 
(Figure 3). Importantly, and as intended, the hard t sk was more challenging than the easy task with 
both groups showing a main effect of task (F(1,38) = 46.0, P < 0.0001, mixed ANOVA, Figure 3). 
Fibromyalgia patients and controls showed a similar drop in performance when comparing the easy 
with hard tasks as there was no interaction between task performance and group, (F(1,38) = 2.7, P = 
0.11). Further analysis indicated that stimulus temp rature had no effect on task performance (main 
effect of temperature F(1,38) = 0.2, P = 0.63), and there was no interaction between task and 










The behavioural results indicated that the fibromyalgia patients had thermal hyperalgesia and 
overall a lower level of performance on the RSVP task, but when these factors were mitigated by 
adjusting stimulus temperature to percept and task speed to performance (in the pre-scanner 
session), they could still produce attentional analgesia.  However, it was not clear if they recruited 
the same brain networks as healthy controls to produce this analgesic effect. Therefore, the same 
analysis strategy used for the behavioural pain ratgs was also applied to the fMRI data. To 
determine main effects in the patterns of activation in brain and the brainstem, data from both 
groups were pooled and subsequently differences between the subject groups was explored.  
Whole brain analysis of the main effect of temperature in pooled group data revealed an 
expected pattern of activity in forebrain regions commonly seen in pain imaging studies including 
prominent clusters in the contralateral (i.e. right) dorsal posterior insula, primary somatosensory 
cortex and anterior cingulate cortices (Figure 4A, Table 2). Brainstem region-masked analyses 
showed a main effect of temperature in the RVM (Figure 4A). Analysis of group level differences 
in the whole brain response to temperature, showed no differences bar the singular exception of an 
enhanced response in healthy controls in the frontopolar cortex (Brodmann Area 10, Figure 4B, 
Table 2). Similar analyses in the brainstem showed a group level difference in the left LC, again 
with an enhanced response in healthy controls (Figure 4B). Imaging data available at: 
https://identifiers.org/neurovault.collection:9513. 
To explore the possible origins of these differences w  conducted an exploratory analysis based 
on the observed need to use a hotter high temperature stimulus for the healthy controls than for 
fibromyalgia patients (Figure 1E). Therefore, the correlation of BOLD signal change for each area 
(BA10 and LC) and difference between the high and low applied temperatures was calculated. The 
left LC BOLD signal showed a positive correlation with the difference between high and low 








temperature might account for the group level difference. A similar analysis did not reveal any 
correlation between temperature delta and activity n BA10 (R=0.19, P=0.47). 
Whole brain analysis of the main effect of task in the pooled data showed a famili r pattern of 
increased activity in the visual attention network including: lateral occipital cortex; superior parietal 
lobule, anterior insula and anterior cingulate cortex, and a decrease in activity in the precuneus and 
fronto-medial cortex  (Figure 5A, Table 2). Brainstem region masked analyses showed a main 
effect of task in the PAG, RVM and left LC (Figure 5B). No difference between the fibromyalgia 
and control groups was detected in the main effect of task at whole brain or brainstem level.  
Imaging data available at: https://identifiers.org/neurovault.collection:9513. 
No task*temperature or task*temperature*group interaction (that could be the neural substrate of 
the observed behavioural interaction between task and temperature i.e. attentional analgesia) was 
seen at the whole brain or brainstem level. 
A planned analysis sought correlations between the fMRI data (individual BOLD differences 
between hard|high and easy|high conditions) and the change in pain scores (i.e. analgesic effect, 
easy|high minus hard|high) to improve the power to identify possible neurobiological substrates of 
the analgesic effect [9,59]. The whole brain regression analysis (i.e. inter-subject) did not identify 
any significant regions showing correlation. However, masked brainstem analyses with the same 
model showed a positive correlation between analgesic effect and the change in activity in both the 











In this study we demonstrate that, contrary to our expectation at the outset, fibromyalgia patients 
can produce attentional analgesia with similar efficacy to healthy volunteers. Analysis of the pain 
ratings during the fMRI experiment revealed that diversion of attentional focus attenuated the pain 
reported in response to a hot thermal stimulus. This result is in contrast to previous evidence of 
malfunctioning endogenous pain modulation in fibromyalgia [42,44,48,74,80]. The specific 
exemplar of conditioned pain modulation has consistently been found to be impaired in 
fibromyalgia patients [8,32,62,65,71], up to the point f becoming a test used for the evaluation of 
novel pharmaceutical therapies [86]. It should be noted however that two previous reports have 
provided some evidence that attentional analgesia may be preserved in fibromyalgia patients. 
Evoked pain was decreased while performing a Stroop task [22,51]. Although neither study was 
able to show significant difference in pain scores (i.e. analgesia) between the easy (congruent) and 
hard (incongruent) version of the Stroop task. By controlling for task performance, we can identify 
that it is the cognitive task difficulty that is modulating pain percept and so demonstrate that  this 
form of attentional pain modulation is intact in fibromyalgia patients. 
Other types of endogenous pain modulation such as placebo and music also produce some pain 
relief in fibromyalgia patients [23,27,34,61], although with lower efficacy in patients with a longer 
disease duration [45]. It therefore seems that cognitive modulation of pain more generically is 
functional in fibromyalgia and this may be a point of difference with conditioned pain modulation 
which is mediated by more of a hindbrain mechanism without a need for cortical drive. It has been 
proposed that the lack of analgesia induced by exercise or by a conditioned stimulus in fibromyalgia 
is caused by the engagement of pain facilitatory networks [32,41,48]. Another possibility is that the 
cortex-brainstem-spinal cord modulatory system is disrupted in fibromyalgia patients and that they 








the finding of unchanged spinal withdrawal reflex during placebo analgesia, despite the reduction in 
pain scores, suggesting that the spinal cord activity was not modulated [27] however this is at odds 
with other studies of placebo analgesia in healthy volunteers that have demonstrated a clear spinal 
modulation using fMRI [18,19]. These contrasting findings with placebo analgesia raise the 
question of whether attentional analgesia in fibromyalgia patients is mediated by engagement of 
descending control mechanisms as has been reported in h althy subjects [9,59]. 
To resolve the brain regions involved in attentional analgesia, we used the same brainstem 
optimised imaging strategy as in our previous studies [9,59]: the analgesic effect in both groups 
correlated with the BOLD change PAG and RVM. This showed a positive linear relationship with 
the analgesic effect and suggests that these regions are mediating attentional analgesia. This is 
consistent with the proposition that fibromyalgia patients can indeed recruit the descending pain 
modulatory system to generate attentional analgesia. Conclusive, direct evidence that PAG and 
RVM modulate the spinal cord during attentional analgesia is not yet present, but it has been 
repeatedly suggested [9,59,73,76]. Functional imaging of brainstem and spinal cord during an 
endogenous analgesia paradigm would help clarifying this issue by determining whether attentional 
analgesia is mediated by descending control from brainstem to spinal cord to regulate nociception. 
Quantitative sensory testing revealed thermal hyperalg sia in fibromyalgia patients in response 
to both hot and cold stimuli, which is similar to tha  previously reported by other research groups 
[5,8,36,65]. We also saw an apparently conflicting small increase in warm detection threshold 
without a change in cold detection threshold  in fibromyalgia patients. These slightly contradictory 
findings could fit with the proposition that this is due to altered functioning in primary afferents due 
to a latent small fibre neuropathy [17,77] and hyperexcitable C-nociceptors [72]. On the other hand, 
recent evidence from a laser evoked potential study, failed to reveal the expected abnormal 








stimuli we took account of the altered sensitivity between the groups and the data from our imaging 
protocol does not shed any further light on this ongoi g debate. 
An alternative hypothesis regarding the aetiology of fibromyalgia is that the hyperalgesia is be due 
to altered central processing [12,15,30,66]. In support of this idea, it is worth noting that aberrant 
sensitivity is found in fibromyalgia patients in many body locations and across sensory modalities 
(e.g., thermal and mechanical pain [5]). Our results indicate that the fibromyalgia patients show a 
similar pattern of brain activation to the healthy controls in response to the percept-matched thermal 
stimulus (like Gracely et al. [30]) and there was no group difference in BOLD in response to task 
difficulty. However, we did find a difference between fibromyalgia patients and controls in the 
anterior prefrontal cortex (BA10) and in the left locus coeruleus in the main effect of temperature. 
Interestingly, the BOLD change in the LC correlated with the temperature used for the attentional 
analgesia experiment.  Animal and human studies have shown that the LC is activated by noxious 
thermal stimuli [35,59]. A similar relationship between human LC activity and thermal stimulus 
intensity has been made using pupillometry in healty subjects [20]. Therefore, it is possible that 
the difference in LC activity in this contrast is due to the patients receiving a significantly lower 
temperature compared to controls (to achieve the same pain score). On the other hand, the BOLD 
signal difference between the groups in BA10 does not correlate with applied temperature but is 
possibly related to cognitive aspects of pain perception [63]. This region has been found to 
consistently respond to painful stimulus in healthy volunteers using a variety of imaging modalities 
(e.g. fMRI, NIRS and PET [63]) and it was reported hat patients with fibromyalgia show reduced 
grey matter density in this and in adjacent cortical regions [47].  We also note a previous study 
comparing the response to pressure stimulation showed an area that was more active in control 
subjects than fibromyalgia patients that includes BA10 [30]. In addition, grey matter density in this 
area was reported to correlate negatively with the intensity of chronic pain [25,46,54,57]. Thus, this 








is yet to be fully elucidated [63]. Therefore, the difference between the groups in BA10 activity in 
our study may well relate to the impact of an ongoi level of spontaneous pain (chronically 
present) seen in the fibromyalgia patients that is not seen in the healthy controls. Our experimental 
design cannot demonstrate whether this is causally related.  Overall, our findings do not provide 
evidence of substantial abnormalities in central pain rocessing in the fibromyalgia group and 
indeed show that the nociceptive processing as well as the engagement of descending control 
centres have many similarities.  
We calibrated the hard version of the attentional task for each participant with the objective of 
achieving comparable cognitive load within and between groups (as per our previous studies 
[9,59]). We found that the inter-character presentation interval was significantly longer in the 
fibromyalgia group compared to healthy controls. This is in line with previous findings reporting 
prolonged reaction times in the fibromyalgia group in, for example, a Stroop task [51,79] and 
supports the evidence of impaired attentional/cognitive processes in fibromyalgia patients. It has 
been proposed that such behavioural impairments are reflected by abnormal functioning of the 
caudate nucleus and hippocampus [51], a finding that is not reproduced in the present study, which 
is to be expected because we adjusted task difficulty between the groups to produce equivalent 
performance which would mask any differences. Interestingly however, during the experimental 
phase the fibromyalgia patients performed worse than controls. This result may be consistent with 
the observation that painful stimulation has a disruptive impact on the cognitive ability of patients, 
possibly because of hypervigilance and catastrophizing [2,14,22,28]. Nevertheless, it is important to 
note that even during the experiment, a contrast in performance between easy and hard task was 
present in fibromyalgia patients. Indeed, the perceived difference in difficulty between the hard and 
easy task was homogeneous between groups, as evidenced by the absence of group difference in the 








A limitation of this study is that we were not able to precisely age match the control subjects 
with the fibromyalgia patients and by chance ended up with a significantly younger control group 
(by 8 years on average).  Exploration of the influence of age, by inclusion as a covariate, in the 
analysis of the main effects of task and temperature and their interaction on pain scores, the heat 
and cold pain thresholds, and upon task performance in experiment did not substantially change the 
significance of any of our findings and so we do not believe that the difference in ages between the 
groups accounted for our findings. 
In conclusion, the present study demonstrate that fibromyalgia patients are able to produce 
analgesia when engaged in a task that diverts their cognitive focus from a noxious stimulus. To this 
end, they engage brainstem nuclei in the same manner s healthy controls. This new evidence 
suggests that, contrary to what was believed, at least some of the elements of the pain descending 
modulatory system are functional in fibromyalgia patients and are available to be recruited.  This 
also lends weight to the idea that therapeutically encouraging fibromyalgia patients to participate in 
cognitively engaging activities (as part of a multimodal rehabilitation package) may represent a 
useful therapeutic strategy as it may both aid their cognitive function and engage their descending 
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Figure 1. Quantitative Sensory Testing and calibration. Quantitative Sensory Testing showed 
patients with fibromyalgia had smaller A) heat pain thresholds B) cold pain threshold and C) 
pressure pain threshold. D) The fibromyalgia patients also have an elevated warm detection 
threshold. E) The thermode temperature used for the High thermal stimulus was lower in the 
fibromyalgia patients. F) The inter-character interval for the RSVP task was longer in the 
fibromyalgia patients. Data presented as mean±SEM and comparison between groups with unpaired 
t-test except for C,D&E which are Median [IQR] and analysed with Mann-Whitney test (* - 
P<0.05, ** - P<0.01). 
 
Figure 2. Pain ratings during the attentional analgesia experiment. A) Pain ratings for each 
subject across experimental conditions (easy and hard task and low and high temperatures) pooled 
across groups (n=40) and the same data is shown B) split into fibromyalgia patients (n=20) and C) 
healthy controls only (n=20). Mixed ANOVA showed a m in effect of temperature and a 
task*temperature interaction mediated by a reduction in the pain scores in the Hard| High condition 
(planned post hoc paired t-test). Mean±SEM. (*** - P<0.001) 
 
Figure 3. Task performance during the attentional analgesia experiment. Task performance 
(d’) in the scanner showing that the hard task was more challenging than the easy task for both (A) 
fibromyalgia patients and (B) healthy controls. Mean±SEM. (Mixed ANOVA, Main effect of task - 
*** - P<0.001). 
 
Figure 4. Main effect of temperature. Main effect of temperature in fibromyalgia patients and 
healthy controls in the whole brain, showing activity in dorsal posterior insula (dpIns), anterior 








corrected P < 0.05), and in the Rostroventromedial medulla (RVM, TFCE corrected P < 0.05). B) 
Group difference in the main effect of temperature in the whole brain, showing a stronger response 
in healthy controls in both Brodmann area 10 (BA10, Z>3.1 cluster corrected P < 0.05) and in the 
left Locus Coeruleus (LC, TFCE corrected P < 0.05). The correlation between main effect of 
temperature in LC and difference in temperatures betwe n low and high (Pearson’s R = 0.49, P = 
0.002, dotted 95% confidence interval). Abbreviations: OPC – Operculum, Pcu – Precuneus. 
 
Figure 5. Main effect of task. Main effect of task in the pooled data from fibromyalgia patients 
and healthy controls (A) in the whole brain, showing i creased activity in lateral occipital cortex 
(LOC), anterior insula (aIns) and anterior cingulate cortex (ACC) (red-yellow), and a decrease in 
activity in precuneus (Pcu), lateral occipital cortex and the frontomedial cortex (FMC, Z>3.1 cluster 
corrected P < 0.05). (B) Main effect of task in thebrainstem: in the Periaqueductal gray (PAG), 
RVM and left LC (TFCE corrected P < 0.05). Abbreviations: SPL – superior parietal lobule. 
 
 
Figure 6. Direct relationship between BOLD and analgesia. Activity in the PAG and the 
RVM correlates with the attentional analgesic effect.  Inter-subject parametric regression between 
BOLD in PAG and RVM with the analgesic effect (i.e. d lta pain ratings of easy|high – 














Healthy                     
controls 
Significance 
Widespread Pain Index (ACR) 13.5±2.6  1.0±1.0 N/A 
Symptom Severity (ACR) 10±1.5 2±1.1 N/A 
Pain now (BPI) 5.3±1.6 0.1±0.2 P < 0.0001 
Pain on average (BPI) 6.4±1.7 0.7±1.0 P < 0.0001 
PainDETECT 15.7± 8.2 2.4±3.3 P < 0.0001 
Hospital Anxiety (HADS) 12.2±3.6 4.6±4.0 P < 0.0001 
Hospital Depression (HADS) 10.5±4.7 1.3±1.3 P < 0.0001 
Pain anxiety symptom (cognitive) 18.4±4.3 5.3±6.6 P < 0.0001 
Pain anxiety symptom (avoidance) 14.6±5.6 5.8±5 P < 0.0001 
Pain anxiety symptom (fear) 11.2±6.8 1.6±1.9 P < 0.0001 
Pain anxiety symptom (anxiety) 11.6±5.5 1.5±2.4 P < 0.0001 
 
Table 1. Results of questionnaires in fibromyalgia patients and healthy controls. All 
comparisons with unpaired t-test with the exception of PAS which is a one way ANOVA with 











Voxels Z Max X (mm) Y (mm) Z (mm) Atlas labels 
Main effect of temperature pooled groups 
2676 7 42 -12 8 83% Central Opercular Cortex 
1605 4.86 0 -74 -14 100% Vermis VI 
1292 6.09 -36 4 8 66% Central Opercular Cortex 
238 4.58 2 -62 54 69% Precuneous Cortex 
166 4.87 24 -40 70 39% Superior Parietal Lobule, 33% 
Postcentral Gyrus 
156 4.19 -20 -84 -38 100% Left Crus II 
121 4.48 0 30 28 70% Cingulate Gyrus, anterior 
division, 13% Paracingulate Gyrus 
90 4.23 -54 -30 18 70% Parietal Operculum Cortex, 6% 
Central Opercular Cortex, 6% 
Supramarginal Gyrus, anterior 
division, 5% Planum Temporale 
85 4.81 -48 -66 -30 81% Left Crus I 
84 4.53 -4 22 44 78% Paracingulate Gyrus, 7% 
Superior Frontal Gyrus 
79 4.73 2 -10 44 73% Cingulate Gyrus, anterior 
division, 17% Cingulate Gyrus, 
posterior division 
77 4.16 -50 44 -10 83% Frontal Pole 
73 3.85 -20 -88 -24 13% Occipital Fusiform Gyrus, 66% 
Left Crus I 
72 4.11 16 -14 6 97% Right Thalamus 
65 4.34 30 -26 62 39% Postcentral Gyrus, 27% 
Precentral Gyrus 
62 3.93 4 -6 12 34% Left Thalamus 
62 4.71 -28 -50 -48 70% Left VIIIa, 14% Left VIIb 
58 3.98 -38 62 8 54% Frontal Pole 
56 3.77 -54 -52 48 46% Angular Gyrus, 33% 
Supramarginal Gyrus, posterior 










Group differences in main effect of temperature (Controls > Patients) 
124 3.98 -22 60 18 71% Frontal Pole 
58 3.87 20 54 16 45% Frontal Pole 
Main effect of task – pooled groups 
4234 6.22 -30 -94 8 5% Lateral Occipital Cortex 
3671 6.68 34 -86 4 21% Lateral Occipital Cortex, inferior 
division 
1147 6.27 8 28 30 48% Paracingulate Gyrus, 22% 
Cingulate Gyrus, anterior division 
887 5.47 32 24 2 54% Frontal Operculum Cortex, 11% 
Inferior Frontal Gyrus, pars 
opercularis, 5% Inferior Frontal 
Gyrus, pars triangularis 
382 5.53 -30 28 -2 54% Insular Cortex 
273 5 -48 0 32 43% Precentral Gyrus, 12% Middle 
Frontal Gyrus, 11% Inferior Frontal 
Gyrus, pars opercularis 
182 4.03 -4 -42 -20 43% Left I-IV 
156 4.26 28 -52 54 43% Superior Parietal Lobule, 12% 
Angular Gyrus 
155 4.96 -8 -70 -16 98% Left VI 
140 5.27 4 -30 -4 70.9% Brain-Stem 
130 4.59 -54 -20 2 51% Planum Temporale, 10% 
Heschl's Gyrus (includes H1 and H2) 
104 4.25 -8 -74 -38 64% Left Crus II, 31% Left VIIb 
54 3.75 -24 -68 -54 92% Left VIIb 
Negative main effect of task – pooled groups 
691 4.59 -6 -60 30 62% Precuneous Cortex 
360 4.7 -38 -72 46 












66% Lateral Occipital Cortex, superior 











Table 2. Results from main effect analyses in the whole brain obtained with cluster-forming 
threshold Z>3.09 and cluster-corrected p<0.05. The tables were created with Autoaq (part of FSL), 
with atlas labels based on the degree of overlap with probabilistic atlases (Harvard Oxford Cortical 
Structural Atlas, Harvard Oxford Subcortical Structural Atlas, Cerebellar Atlas in MNI152 space 
after normalization with FNIRT). Only those structures to which the cluster had a >5% chance of 










































































































































































-28 -16 -4 4












































X = -12 Z = - 10
X = -4 Z = - 23
X = -2 Z = - 40
Main effect of task – FM and HC pooled
Whole brain
Brainstem – FM and HC pooled
-28 -16 -4 8











Correlation with analgesic effect
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